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Takeshi Miyatsuka, Zhongmei Li, and Michael S. German
OBJECTIVE—Neurogenin 3 plays a pivotal role in pancreatic
endocrine differentiation. Whereas mouse models expressing
reporters such as eGFP or LacZ under the control of the Neurog3
gene enable us to label cells in the pancreatic endocrine lineage,
the long half-life of most reporter proteins makes it difficult to
distinguish cells actively expressing neurogenin 3 from differen-
tiated cells that have stopped transcribing the gene.
RESEARCH DESIGN AND METHODS—In order to separate
the transient neurogenin 3 –expressing endocrine progenitor
cells from the differentiating endocrine cells, we developed a
mouse model (Ngn3-Timer) in which DsRed-E5, a fluorescent
protein that shifts its emission spectrum from green to red over
time, was expressed transgenically from the NEUROG3 locus.
RESULTS—In the Ngn3-Timer embryos, green-dominant cells
could be readily detected by microscopy or flow cytometry and
distinguished from green/red double-positive cells. When fluores-
cent cells were sorted into three different populations by a
fluorescence-activated cell sorter, placed in culture, and then
reanalyzed by flow cytometry, green-dominant cells converted to
green/red double-positive cells within 6 h. The sorted cell popu-
lations were then used to determine the temporal patterns of
expression for 145 transcriptional regulators in the developing
pancreas.
CONCLUSIONS—The precise temporal resolution of this
model defines the narrow window of neurogenin 3 expression in
islet progenitor cells and permits sequential analyses of sorted
cells as well as the testing of gene regulatory models for the
differentiation of pancreatic islet cells.Diabetes 58:1863–1868,
2009
The mature pancreas is composed of exocrine(acinar and duct cells) and endocrine (-, -, -,ε-, and PP-cells) compartments. The differentia-tion of these distinct cell types is regulated by
the coordinated expression of numerous transcription
factors (1–3). Among these transcription factors, neuroge-
nin 3 (Neurog3), a member of the basic helix-loop-helix
transcription factor family, plays essential roles in ini-
tiating endocrine differentiation during embryonic de-
velopment, regeneration, and transdifferentiation into
functional insulin-producing cells (4–9). In addition, the
transient nature of Neurog3 expression makes it a useful
marker for uniquely identifying endocrine progenitor
cells—cells that have committed to the endocrine lineage
but have not yet differentiated into hormone-producing
endocrine cells (10,11).
Mouse models expressing fluorescent reporter proteins
have been used to sort specific cell populations. For
example, cells sorted from Ngn3-eGFP mouse lines gener-
ated by different groups have been used to examine gene
expression profiles during pancreatic endocrine differen-
tiation (12,13). However, because of the long half-life (14),
fluorescent reporter proteins persist after the Neurog3
gene itself has shut off; thus, the fluorescent cell popula-
tion includes cells at different stages of differentiation.
Destabilized fluorescent proteins have shorter half-lives
but lower fluorescence (15). In addition, sorting cells at
earlier time points may decrease the overlap with more
differentiated cells as described previously (13); however,
this approach cannot be used at later time points or for
distinguishing more mature cells.
To solve this problem, we developed a novel transgenic
mouse model (Ngn3-Timer) in which human NEUROG3
upstream and downstream sequences were used within a
bacterial artificial chromosome (BAC) to drive expression
of DsRed-E5, a variant of the Discosoma sp. red fluores-
cent protein that shifts its fluorescence emission peak
from green to red in a time-dependent manner (16). Using
fluorescence microscopy, green fluorescence could be
detected in developing pancreata of Ngn3-Timer embryos
as early as embryonic day 9.5 (E9.5) (data not shown).
Both green and red fluorescent signals were readily de-
tected in developing pancreata of Ngn3-Timer embryos
from E12.5 to E18.5, whereas predominantly red fluores-
cence was observed at postnatal day 7 (P7) (supplemental
Fig. 1, available in the online appendix at http://diabetes.
diabetesjournals.org/cgi/content/full/db09-0390/DC1), con-
sistent with previous reports that few Neurog3-expressing
cells persist after birth (5). At E17.5, histological analyses
detected green-dominant and green/red double-positive
fluorescent cells in close apposition with the ductal lumen,
whereas red-dominant cells appeared in islet-like clusters
(Fig. 1A), supporting a model whereby cells in the endo-
crine lineage emerge from ductal regions as Neurog3-
positive cells and migrate away from the ductal region as
differentiation progresses. Consistent with this model,
staining for Neurog3 protein overlapped with predomi-
nantly green-dominant cells and some green/red double-
positive cells (supplemental Fig. 2), whereas insulin
staining overlapped with green/red double-positive cells
and red-dominant cells (supplemental Fig. 3).
To quantify the shift in fluorescence during endocrine
cell differentiation, flow cytometric analyses were per-
formed with dissociated cells isolated from Ngn3-Timer
mice. Labeled cells isolated from E13.5 pancreata emitted
fluorescence predominantly in the green channel; how-
ever, a progressive increase in red fluorescence was
observed in older embryos until P0, when the number of
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green-dominant cells dramatically declined compared with
the earlier time points and most labeled cells fluoresced in
the green/red double-positive area (Fig. 1B). These data
support the hypothesis that the DsRed-E5 protein initially
expressed in the Neurog3 lineage emits in the green
spectrum and that as the cells turn off Neurog3 expres-
sion, age, and differentiate, it shifts to the red emission
spectrum.
green red merge A
0 10 2 10 3 10 4 10 5 
0 
10 2 
10 3 
10 4 
10 5 
0 10 2 10 3 10 4 10 5 
0 
10 2 
10 3 
10 4 
10 5 
0 10 2 10 3 10 4 10 5 
0 
10 2 
10 3 
10 4 
10 5 
0 10 2 10 3 10 4 10 5 
0 
10 2 
10 3 
10 4 
10 5 
0 10 2 10 3 10 4 10 5 
0 
10 2 
10 3 
10 4 
10 5 
0 10 2 10 3 10 4 10 5 
0 
10 2 
10 3 
10 4 
10 5 
red fluorescence
gr
ee
n 
flu
or
es
ce
nc
e
E13.5, wild type E17.5, wild type P0, wild typeB
E13.5, Ngn3-Timer E17.5, Ngn3-Timer P0, Ngn3-Timer
erge 
FIG. 1. Expression of the DsRed-E5 fluorescent protein in developing pancreas. A: The pancreas was dissected from an Ngn3-Timer embryo at
E17.5 and stained with DBA lectin, a marker of pancreatic duct (blue). Green-dominant cells detected within ducts are labeled with white arrows;
green/red double-positive and red-dominant cells (yellow or orange in color, right panel) are labeled with orange arrowheads. Scale bar: 50 m.
B: Pancreata from wild-type (A–C) and Ngn3-Timer mice (D–F) were dissociated at E13.5, E17.5, and P0 and analyzed using flow cytometry. Green
fluorescence is shown on the vertical axis and red fluorescence on the horizontal axis. (A high-quality digital representation of this figure is
available in the online issue.)
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To verify this hypothesis and estimate the temporal
resolution of this model, fluorescent cells were sorted by a
fluorescence-activated cell sorter (FACS) into four differ-
ent populations, placed in culture, and then reanalyzed by
flow cytometry at various time points following culture.
Green-dominant cells, sorted from gate A in Fig. 2, con-
FIG. 2. Time-dependent shift of fluorescence in sorted cells after culture. Ngn3-Timer pancreata were dissociated at E17.5 and sorted by FACS.
The sorted cells from the gates shown were analyzed immediately after FACS by flow cytometry (first column) or placed in culture and analyzed
by flow cytometry after 3 h (second column), 6 h (third column), and 12 h (fourth column).
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verted to green/red double-positive within 6 h, whereas
green/red double-positive cells in gate B converted to the
lower green/red ratio (red dominant) of gate C cells within
12 h. Therefore, the green-dominant cells were within a 6-h
time window after initial DsRed-E5 expression and green/
red double-positive cells within a 12-h time window. On
the other hand, the fluorescent cells sorted using gate C
changed little over 12 h, presumably because of the long
half-life of DsRed-E5.
Real-time PCR analyses performed on RNA from cells
sorted by FACS into the four populations defined in Fig. 2
confirmed the sequential maturation of these cells. The
expression level of Neurog3 was highest in green-domi-
nant cells and dramatically decreased in green/red double-
positive cells (Fig. 3A), reflecting the rapid downregulation
of Neurog3 once it has initiated endocrine differentiation.
Expression of the islet hormones peaked later (Fig. 3B–D),
with the mRNA encoding insulin and glucagon highest in
cells from gate C, the most mature population.
To gauge the expression of known pancreatic transcrip-
tional regulators (13,17) in these differentiating cell popu-
lations, TaqMan RT-PCR assays were performed with RNA
from cells isolated by FACS from E17.5 Ngn3-Timer pan-
creata. The expression levels of 145 genes were normal-
ized to -glucuronidase, and the relative level of mRNA
from each gate was determined with respect to the value
in nonfluorescent cells (gate N). For 21 genes, expression
in the earliest progenitor cells (gate A) exceeded expres-
sion in the nonfluorescent cells by more than 10-fold (gate
[A]/gate [N] 10; Fig. 3E–J and supplemental Table).
Among these genes, three (Neurog3, Pax4, and Mycl1)
demonstrated a sharp expression peak in gate A, with a
subsequent decline of more than 10-fold from gate A to
gate C (Fig. 3J)—which is consistent with the conclusion
that these genes have expression restricted to the islet
progenitor cells. These data confirm previous evidence
that Neurog3 directly activates transient Pax4 gene ex-
pression followed by repression by Pax4 (18). The profile
of Mycl1 paralleled those of Neurog3 and Pax4; therefore,
it may also play a specific role in the transient endocrine
progenitor cells.
Several of the other genes, including NeuroD, Nkx2.2,
Myt1, and Insm1, are also known targets of Neurog3 but
persist in mature islet cells (1–3). In addition, this ap-
proach identified several factors with known expression in
the pancreas (13,17) but without known roles in the
Neurog3 pathway, including Mycl1, Mnt, Nfatc2, Pou2f2,
Sim1, and Fev. Fev, which encodes an ETS transcription
factor and showed the highest relative induction in the
gate A cells (Fig. 3E), and we have recently confirmed its
expression and function in the islet lineage (Y. Ohta and
M.S.G., unpublished data). Finally, Rfx6, a member of the
Rfx family of winged-helix transcription factors, has not
been studied in the pancreas previously, but these data
place it in the Neurog3 pathway and islet lineage.
Of the 145 genes only three, Mafa, Hopx, and Myt1l,
showed a robust increase from gate A to gate C (Fig. 3K)
that paralleled the expression profiles of Ins1 and Ins2
(Fig. 3B and C). MafA appears late in pancreatic develop-
ment specifically in mature -cells (19) and directly trans-
activates the insulin gene in conjunction with NeuroD1
and Pdx1, which are expressed earlier. Therefore, MafA
may play a critical role in the final maturation of -cells. It
follows that Hopx and Myt1l potentially also contribute to
the maturation of the endocrine cells.
As expected, Ptf1a and Rbpjl, known exocrine genes,
were confined to gate N (Fig. 3L). On the other hand,
mRNA encoding Hes1, Notch2, and Onecut1 (Hnf6), which
regulate the expression of Neurog3 (4,20,21), persisted in
gate A but rapidly declined as cells matured (Fig. 3M).
In summary, the Ngn3-Timer mouse provides a useful in
vivo tool for temporal dissection of the differentiation
processes. The model allowed us to accurately isolate
cells from distinct narrow time points along the differen-
tiation pathway and also to study the characteristics of
those cells. We have used this tool to identify genes that
likely play unique roles at these different steps of differ-
entiation. The availability of this tool also permits rela-
tively facile methods for studying signals that impact the
initiation or completion of differentiation, the rate of
differentiation, or the proliferation or death of differenti-
ating cells. Likewise, similar transgenic models could be
used to study the temporal features of differentiation in
other cell populations.
RESEARCH DESIGN AND METHODS
Generation of Ngn3-Timer transgenic mouse. Starting with a BAC con-
taining 134 kb upstream and 30 kb downstream of the human NEUROG3 gene
(clone RP11-343J3 [Sanger Institute, U.K.]), the NEUROG3 coding sequence
was replaced by the DsRed-E5 coding region (pTimer; Clontech, Palo Alto,
CA) via homologous recombination. The modified BAC was purified using
cesium chloride gradient ultracentrifugation, dialyzed, and microinjected into
the pronuclei of B6SJL/F1 oocytes to generate the Ngn3-Timer transgenic
mice. The mice were genotyped by PCR using the forward primer 5-
cgctgctcatcgctctcta-3 in the 5-flanking sequence of NEUROG3 and the
reverse primer 5-GGTGTTGTGGCCCTCGTAG-3 in the coding region of
DsRed-E5. A total of six lines of Ngn3-Timer mice were generated and
analyzed by means of flow cytometry and microscopy, and two highly
fluorescent lines were maintained for further analyses. Both high-expressing
lines gave the same expression pattern. One of these two lines was used for
all of the studies reported here.
Mice were housed on a 12-h light/dark cycle in a controlled climate. Timed
matings were carried out with E0.5 being set as midday of the day of discovery
of a vaginal plug. All studies involving mice were approved by the University
of California San Francisco Institutional Animal Care and Use Committee.
Whole-mount observation and histological analyses. Transgenic Ngn3-
Timer embryos were killed from E12.5 to P7, and macroscopic appearance
and fluorescence of the Ngn3-Timer mice were examined using the fluorescent
dissecting microscope. For histological analyses, tissues were fixed in 4%
paraformaldehyde in PBS at 4°C, washed in PBS alone, and then immersed
into sucrose solution in PBS overnight at 4°C. The next day, the tissues were
embedded and frozen in Tissue-Tek (OCT Compound, Sakura). Tissues were
sectioned at 6 m, permeabilized with 0.1% Triton X-100, blocked with 5% goat
serum (Invitrogen) and incubated with biotinylated lectin Dolichos biflorus
agglutinin (DBA; Vector Laboratories) diluted 1:200 in PBS, and then visual-
ized using Alexa Fluor 350–conjugated streptavidin (Molecular Probes, Eu-
gene, OR).
Pancreatic cell dispersion and flow cytometry. The Ngn3-Timer trans-
genic mice were distinguished from control littermates using the fluorescent
dissecting microscope, and the whole pancreata were manually dissected
from other organs. Pancreata were treated with 0.05% trypsin/0.53 mmol/l
EDTA (Invitrogen, Carlsbad, CA) at 37°C for 5 min, and the digestion was
inactivated by addition of FBS. The dissociated cells were resuspended in
FACS buffer (2% FBS in PBS) and then analyzed using an LSRII flow cytometer
(PerkinElmer) or sorted using a MoFlo cell sorter (Dako Cytomation, Carpin-
teria, CA). Dead cells were excluded with DNA dye TO-PRO-3 (Molecular
Probes, Eugene, OR).
Cell culture. The Ngn3-Timer pancreata were dissociated at E17.5 and sorted
by FACS into the different populations shown. The sorted cells were incu-
bated in growth medium (DME H-16 50%/F-12 50% with 10% FBS, antibiotics,
and insulin-transferrin-selenium) at 37°C in 5% CO2. After 2–12 h of culture,
the cells were dissociated with 0.05% trypsin/0.53 mmol/l EDTA, transferred
into FACS tubes, and then analyzed using an LSRII flow cytometer
(PerkinElmer).
Real-time quantitative PCR. Total RNA was extracted from cells sorted by
FACS from three independent groups of E17.5 Ngn3-Timer embryos using the
RNeasy Plus micro kit (Qiagen, Valencia, CA) according to the manufac-
turer’s protocol. The quality and quantity of extracted RNA were assessed
with the Agilent 2100 Bioanalyzer using the RNA 6000 Pico Assay kit
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FIG. 3. Temporal transcriptome analysis in the pancreata of Ngn3-Timer embryos. A–D: Ngn3-Timer pancreata were dissected at E17.5 and sorted
by FACS into four gates (gates A, B, C, and N). The sorted cell populations were analyzed by real-time RT-PCR for mRNA-encoding transcriptional
regulators and endocrine hormones. All expression levels were normalized to -glucuronidase. Neurog3 (A), insulin1 (B), insulin2 (C), glucagon
(D). E–M: TaqMan array was performed for 145 transcription factors. Expression levels are shown relative to the level in gate N. Each data point
represents the mean of three independent experiments.
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(Agilent Technologies, Santa Clara, CA), and 10 nanograms of the total RNA
were linearly amplified and converted into cDNA with the NuGENWT-Ovation
RNA amplification system (NuGen, San Carlos, CA). Individual cDNAs were
quantified by real-time PCR using the TaqMan low density array system
(Applied Biosystems, Foster City, CA), designed for pancreas-specific genes
including endocrine hormones and transcription factors (supplemental Ta-
ble). Gene expression levels of the assayed genes were normalized to the
expression levels of -glucuronidase. The means  SE are shown in the
supplemental Table.
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